{
    "root": "82ad0fdf-5d47-4c2d-883b-f28b2d3fb6b0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Hydrochlorothiazide",
    "value": "20250429",
    "ingredients": [
        {
            "name": "HYDROCHLOROTHIAZIDE",
            "code": "0J48LPH2TH"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "D&C RED NO. 28",
            "code": "767IP0Y5NH"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        }
    ],
    "indications": "Hydrochloro‑thiazide capsules are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combina‑tion diuretic products, hydrochloro‑thiazide capsules may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ACE inhibitors.",
    "contraindications": "For Control of Hypertension: The adult initial dose of hydrochloro‑thiazide is one capsule given once daily whether given alone or in combination with other antihypertensives. Total daily doses greater than 50 mg are not recommended.",
    "warningsAndPrecautions": "Hydrochlorothiazide Capsules USP 12.5 mg are blue/blue size ‘4’ hard gelatin capsules, imprinted with ‘D’ on blue cap and ‘26’ on blue body with black edible ink, filled with white to off-white powder.\n                              Bottles of 7               NDC 68788-8862-7\n                           Bottles of 30               NDC 68788-8862-3\n                           Bottles of 60               NDC 68788-8862-6 \n                           Bottles of 90               NDC 68788-8862-9\n                           Bottles of 100               NDC 68788-8862-1\n                      Dispense in a tight, light-resistant container as defined in the USP.\n                  \n                      \n                  \n                  \n                     Keep out of reach of children.\n                     \n                     \n                      Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from light, moisture, freezing, -20°C (-4°F). Keep container tightly closed.\n                  \n                     \n                      Distributed by:\n                     Rising Pharma Holdings, Inc. East Brunswick, NJ 08816\n                     \n                      Made in India\n                      Code: TS/DRUGS/19/1993\n                     \n                     Revised: 09/2024\n                  \n                     Repackaged By: Preferred Pharmaceuticals Inc.",
    "adverseReactions": "Hydrochlorothiazide capsules are con‑traindicated in patients with anuria. Hypersensitivity to this product or other sulfonamide derived drugs is also con‑traindicated."
}